Penthrox Launched in France and Belgium and first sales
8 February 2017
ASX ANNOUNCEMENT
Penthrox launched in France and Belgium and first sales.
Medical Developments International Limited (ASX: MVP) is delighted to announce Penthrox has been launched in both France and Belgium via its European partner, the Mundipharma network of independent associated companies (Mundipharma).
The “First Commercial Sale” in France triggers a milestone payment of USD$2.0m to MVP which will be received within 30 days.
MVP CEO, Mr John Sharman, said: “The launch of Penthrox in France is an exciting achievement for MVP. France represents a significant market for Penthrox within Europe and pre-launch feedback from the market is extremely positive.”